, Tracking Stock Market Picks
Enter Symbol:

down 99.96 %

BIONOVO INC (BNVI) rated Buy by Dawson James

Posted on: Tuesday,  Nov 3, 2009  9:25 AM ET by Dawson James

Dawson James rated Buy BIONOVO INC (OTCBB: BNVIQ) on 11/03/2009, when the stock price was $2.10. Since
then, BIONOVO INC has lost 99.97% as of 08/14/2015's recent price of $0.00.
If you would have followed this Dawson James's recommendation on BNVIQ, you would have lost 99.96% of your investment in 2110 days.

Bionovo, Inc. is a clinical stage drug discovery and development company focusing on women?s health and cancer. The Company designs drugs derived from botanical sources, which have mechanisms of action. The Company?s drug candidate, Menerba, represents a class of receptor sub-type selective estrogen receptor modulator (SERM) for the treatment of vasomotor symptoms of menopause, or hot flashes. The Company has designed Menerba to selectively modulate estrogen receptor beta (ERβ). In preclinical studies, Menerba inhibited tumor growth, as well as bone resorption known to cause osteoporosis, which is developed during menopause. The Company was developing BZL101, an oral anti-cancer agent for advanced breast cancer during the year ended December 31, 2008. BZL101 is designed to take advantage of the metabolism of cancer cells. BZL101 inhibits glycolysis, a metabolic pathway on which cancer cells rely.

Dawson James Securities is a full service investment firm with deep expertise in healthcare, biotechnology and technology with a staff of over 50 investment professionals ensures our clients stay ahead of the constant changes in the healthcare capital markets. From our widely-respected institutional research, investment banking and high net worth services to our personalized attention for individual accounts, we provide quality service for our clients. We take pride in the quality and depth of our professionals and encourage you to contact us so we can begin serving your financial needs today.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/3/2009 9:25 AM Buy
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy